Example: Heart Attack

Clinical Trials on Purpura, Thrombocytopenic

Total 332 results

NCT04562766

Not yet recruiting

Ph3 Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT04518475

Recruiting

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04518878

Recruiting

Fixed Low-dose Eltrombopag and rhTPO for Immune Thrombocytopenia (FLOWER)

Conditions: Immune Thrombocytopenia
NCT04516837

Recruiting

Eltrombopag Plus rhTPO Versus Eltrombopag for ITP During the COVID-19 Pandemic (ELABORATE-19)

Conditions: Immune Thrombocytopenia
NCT04516967

Not yet recruiting

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Conditions: Immune Thrombocytopenia
NCT04481282

Recruiting

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04428255

Not yet recruiting

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Conditions: Primary Immune Thrombocytopenic Purpura
NCT04368598

Recruiting

The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP

Conditions: Immune Thrombocytopenia
NCT04346654

Recruiting

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia (ITP)
NCT04323748

Not yet recruiting

Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura
NCT04320225

Not yet recruiting

Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04311593

Not yet recruiting

Prognostic Value of CD Markers in Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenia
NCT04289207

Not yet recruiting

Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04278924

Recruiting

Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Participants With Persistent/Chronic Primary Immune Thrombocytopenia

Conditions: Primary Immune Thrombocytopenia
NCT04274452

Withdrawn

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia (ITP)
NCT04224688

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04225156

Recruiting

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04217148

Recruiting

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04214951

Recruiting

A Study of Eltrombopag and Recombinant Human Thrombopoietin In Primary Immune Thrombocytopenia

Conditions: Corticosteroid-resistant or Relapsed ITP
NCT04200456

Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04188379

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04132050

Recruiting

A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04128358

Not yet recruiting

Triple Therapy in Patients With Idiopathic Thrombocytopenic Purpura : What is Behind?

Conditions: Idiopathic Thrombocytopenic Purpura
NCT04113915

Not yet recruiting

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

Conditions: ITP - Immune Thrombocytopenic Purpura; Viral Hepatitis
NCT04102033

Not yet recruiting

Eltrombopag in Chronic ITP

Conditions: Immune Thrombocytopenia
NCT04100876

Not yet recruiting

Effect of DNMT SNPs on DNA Methylation in Primary ITP

Conditions: Primary Immune Thrombocytopenia
NCT04094805

Not yet recruiting

A Multicenter Randomized Study of Vitamin D Combined With HD-DXM Versus HD-DXM for the Treatment of ITP

Conditions: Immune Thrombocytopenia
NCT04089267

Completed

Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)

Conditions: ITP
NCT04083014

Recruiting

Single-dose Anti-CD20 Antibody With Bortezomib for Relapsed Refractory Autoimmune Hemolytic Anemia

Conditions: Autoimmune Hemolytic Anemia; Autoimmune Hemolytic Anemia and Autoimmune Thrombocytopenia
NCT04074187

Recruiting

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Conditions: Thrombotic Thrombocytopenic Purpura
NCT04070599

Completed

Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura.

Conditions: Immune Thrombocytopenic Purpura; Autoimmune Thrombocytopenia; Thrombopenia
NCT04070612

Completed

National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.

Conditions: Cytopenia; Autoimmune Haemolytic Anaemia; Thrombocytopenic Purpura, Immune
NCT04071496

Completed

Diagnostic of Chronic Thrombocytopenia

Conditions: Congenital Thrombocytopenia; Chronic Idiopathic Thrombocytopenic Purpura
NCT04057703

Completed

Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia.

Conditions: Immune Thrombocytopenic Purpura; Autoimmune Hemolytic Anemia; Evan Syndrome; Immunotherapy
NCT04056195

Recruiting

Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT04056507

Completed

Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura

Conditions: Immune Thrombocytopenic Purpura; Splenectomy; Status
NCT04039477

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP

Conditions: Autoimmune Hemolytic Anemia; Immune Thrombocytopenia
NCT04021173

Not yet recruiting

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura
NCT04014166

Recruiting

Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia

Conditions: Thrombocytopenia; Mesenchymal Stem Cells
NCT04014413

Recruiting

Safety and Efficacy of Fecal Microbiota Transplantation

Conditions: Crohn Disease; Ulcerative Colitis; Celiac Disease; Irritable Bowel Syndrome; Functional Dysphonia; Constipation; Clostridium Difficile Infection; Diabetes Mellitus; Obesity; Multidrug -Resistant Infection; Hepatic Encephalopathy; Multiple Sclerosis; Pseudo-Obstruction; Carbapenem-Resistant Enterobacteriaceae Infection; Vancomycin Resistant Enterococci Infection; Multiple Organ Dysfunction Syndrome; Dysbiotic Bowel Syndrome; MRSA Enteritis; Pseudomembranous Enterocolitis; Alopecia; Autism; Graft-versus-host Disease; Idiopathic Thrombocytopenic Purpura; Atopy or Allergy; Liver Disease; Alcohol Dependence; Psoriatic Arthropathy
NCT04005638

Recruiting

Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Conditions: Immune Thrombocytopenia; Autoimmune Hemolytic Anemia; Autoimmune Neutropenia
NCT04003220

Not yet recruiting

Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker

Conditions: Thrombocytopenia; Purpura, Thrombocytopenic; Myelodysplastic Syndromes
NCT03998982

Recruiting

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia
NCT03998059

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Conditions: Thrombocytopenia; Splenectomy
NCT03975361

Not yet recruiting

Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)

Conditions: Immune Thrombocytopenia (ITP); Systemic Lupus Erythematosus (SLE)
NCT03965624

Withdrawn

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Conditions: Immune Thrombocytopenia; Warm Autoimmune Hemolytic Anemia
NCT03951623

Recruiting

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Conditions: Immune Thrombocytopenia (ITP)
NCT03939637

Recruiting

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Conditions: Immune Thrombocytopenia
NCT03922308

Recruiting

Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Conditions: Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
NCT03866577

Recruiting

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Conditions: Immune Thrombocytopenic Purpura (ITP)

COOKIE SETTINGS

Clinical Trials on Purpura, Thrombocytopenic